Pharmacy contribution to the prescription and rational use of human albumin at a large hospital

Detalhes bibliográficos
Autor(a) principal: Borges Filho,Wladimir Mendes
Data de Publicação: 2010
Outros Autores: Almeida,Silvana Maria de, Ferracini,Fabio Teixeira, Fernandes Júnior,Constantino Jose
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Einstein (São Paulo)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000200215
Resumo: ABSTRACT Objective: The purpose of this survey was to reduce the use of human albumin 20% in non-supported indications at Hospital Israelita Albert Einstein. Methods: During a 30-day period, in December 2006, a preliminary prospective analysis of medical prescriptions of human albumin 20% and therapeutic indications according to ANVISA RDC 115 guidelines was performed. Based on this analysis, a project was developed. In January 2007, a daily routine to follow up albumin prescriptions by the Hospital pharmacists was established. Results: From January to October 2007, 14,799 vials of albumin 20% were used, out of which 4,191 had non-supported indications, resulting in a R$ 1.36 million loss. In 2008 (from January to October), 13,519 vials of albumin 20% were prescribed, and 1,648 of them had non-supported indications, causing a R$ 535 thousand loss. The ratio between loss risk and consumed amount was 91.99 between January and October 2007. During the same period in 2008, this ratio was 39.60. Between January and October 2007, the average percentage of albumin prescribed for non-supported indications was 28%, whereas this percentage dropped to 13%, i.e., a decrease by 54%, during the same period of 2008. Conclusions: The inclusion of a pharmacist in the process of verifying medicine indications and justification of use was translated into safer processes to patients, ensuring that they received the correct medication for the correct indication, therefore reducing the chance of adverse events and contributing to reduce red-tape procedures and unnecessary expenditures by the institution.
id IIEPAE-1_0aaab9fce6464bb80ec89c3856d27d40
oai_identifier_str oai:scielo:S1679-45082010000200215
network_acronym_str IIEPAE-1
network_name_str Einstein (São Paulo)
repository_id_str
spelling Pharmacy contribution to the prescription and rational use of human albumin at a large hospitalMedication useAlbuminsPharmacoeconomyClinical pharmacyABSTRACT Objective: The purpose of this survey was to reduce the use of human albumin 20% in non-supported indications at Hospital Israelita Albert Einstein. Methods: During a 30-day period, in December 2006, a preliminary prospective analysis of medical prescriptions of human albumin 20% and therapeutic indications according to ANVISA RDC 115 guidelines was performed. Based on this analysis, a project was developed. In January 2007, a daily routine to follow up albumin prescriptions by the Hospital pharmacists was established. Results: From January to October 2007, 14,799 vials of albumin 20% were used, out of which 4,191 had non-supported indications, resulting in a R$ 1.36 million loss. In 2008 (from January to October), 13,519 vials of albumin 20% were prescribed, and 1,648 of them had non-supported indications, causing a R$ 535 thousand loss. The ratio between loss risk and consumed amount was 91.99 between January and October 2007. During the same period in 2008, this ratio was 39.60. Between January and October 2007, the average percentage of albumin prescribed for non-supported indications was 28%, whereas this percentage dropped to 13%, i.e., a decrease by 54%, during the same period of 2008. Conclusions: The inclusion of a pharmacist in the process of verifying medicine indications and justification of use was translated into safer processes to patients, ensuring that they received the correct medication for the correct indication, therefore reducing the chance of adverse events and contributing to reduce red-tape procedures and unnecessary expenditures by the institution.Instituto Israelita de Ensino e Pesquisa Albert Einstein2010-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000200215einstein (São Paulo) v.8 n.2 2010reponame:Einstein (São Paulo)instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)instacron:IIEPAE10.1590/s1679-45082010ao1630info:eu-repo/semantics/openAccessBorges Filho,Wladimir MendesAlmeida,Silvana Maria deFerracini,Fabio TeixeiraFernandes Júnior,Constantino Joseeng2017-03-14T00:00:00Zoai:scielo:S1679-45082010000200215Revistahttps://journal.einstein.br/pt-br/ONGhttps://old.scielo.br/oai/scielo-oai.php||revista@einstein.br2317-63851679-4508opendoar:2017-03-14T00:00Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)false
dc.title.none.fl_str_mv Pharmacy contribution to the prescription and rational use of human albumin at a large hospital
title Pharmacy contribution to the prescription and rational use of human albumin at a large hospital
spellingShingle Pharmacy contribution to the prescription and rational use of human albumin at a large hospital
Borges Filho,Wladimir Mendes
Medication use
Albumins
Pharmacoeconomy
Clinical pharmacy
title_short Pharmacy contribution to the prescription and rational use of human albumin at a large hospital
title_full Pharmacy contribution to the prescription and rational use of human albumin at a large hospital
title_fullStr Pharmacy contribution to the prescription and rational use of human albumin at a large hospital
title_full_unstemmed Pharmacy contribution to the prescription and rational use of human albumin at a large hospital
title_sort Pharmacy contribution to the prescription and rational use of human albumin at a large hospital
author Borges Filho,Wladimir Mendes
author_facet Borges Filho,Wladimir Mendes
Almeida,Silvana Maria de
Ferracini,Fabio Teixeira
Fernandes Júnior,Constantino Jose
author_role author
author2 Almeida,Silvana Maria de
Ferracini,Fabio Teixeira
Fernandes Júnior,Constantino Jose
author2_role author
author
author
dc.contributor.author.fl_str_mv Borges Filho,Wladimir Mendes
Almeida,Silvana Maria de
Ferracini,Fabio Teixeira
Fernandes Júnior,Constantino Jose
dc.subject.por.fl_str_mv Medication use
Albumins
Pharmacoeconomy
Clinical pharmacy
topic Medication use
Albumins
Pharmacoeconomy
Clinical pharmacy
description ABSTRACT Objective: The purpose of this survey was to reduce the use of human albumin 20% in non-supported indications at Hospital Israelita Albert Einstein. Methods: During a 30-day period, in December 2006, a preliminary prospective analysis of medical prescriptions of human albumin 20% and therapeutic indications according to ANVISA RDC 115 guidelines was performed. Based on this analysis, a project was developed. In January 2007, a daily routine to follow up albumin prescriptions by the Hospital pharmacists was established. Results: From January to October 2007, 14,799 vials of albumin 20% were used, out of which 4,191 had non-supported indications, resulting in a R$ 1.36 million loss. In 2008 (from January to October), 13,519 vials of albumin 20% were prescribed, and 1,648 of them had non-supported indications, causing a R$ 535 thousand loss. The ratio between loss risk and consumed amount was 91.99 between January and October 2007. During the same period in 2008, this ratio was 39.60. Between January and October 2007, the average percentage of albumin prescribed for non-supported indications was 28%, whereas this percentage dropped to 13%, i.e., a decrease by 54%, during the same period of 2008. Conclusions: The inclusion of a pharmacist in the process of verifying medicine indications and justification of use was translated into safer processes to patients, ensuring that they received the correct medication for the correct indication, therefore reducing the chance of adverse events and contributing to reduce red-tape procedures and unnecessary expenditures by the institution.
publishDate 2010
dc.date.none.fl_str_mv 2010-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000200215
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000200215
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s1679-45082010ao1630
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
dc.source.none.fl_str_mv einstein (São Paulo) v.8 n.2 2010
reponame:Einstein (São Paulo)
instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
instname_str Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron_str IIEPAE
institution IIEPAE
reponame_str Einstein (São Paulo)
collection Einstein (São Paulo)
repository.name.fl_str_mv Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
repository.mail.fl_str_mv ||revista@einstein.br
_version_ 1752129905815977984